Protective effect of ultra low molecular weight heparin on glutamate-induced apoptosis in cortical cells

Yonsei Medical Journal

Volumn 49, Issue 3, 2008, Pages 486-495

  Yu, Tian Gui ^a   Zhang, Qing Zhu ^a   Zhang, Zhi Guo ^a   Wang, Wei Wei ^a   Ji, Sheng Li ^a   Du, Guan Hua ^b  

^a SHANDONG UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; Bax; Bcl 2; Ca2+; Caspase 3; Glutamate; Ultra low molecular weight heparin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; CALCIUM ION; CASPASE 3; GLUTAMIC ACID; HEPARIN DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; ULTRA LOW MOLECULAR WEIGHT HEPARIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CELL; CALCIUM CELL LEVEL; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUOROMETRY; GEL ELECTROPHORESIS; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CALCIUM; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DNA FRAGMENTATION; GLUTAMIC ACID; HEPARIN, LOW-MOLECULAR-WEIGHT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR;

EID: 48649091705     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.3.486     Document Type: Article

References (50)

1. Bergamaschini L, Rossi E, Storini C, Pizzimenti S, Distaso M, Perego C, et al. Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease. J Neurosci 2004;24:4181-6.
2. Zhu H, Yu J, Kindy MS. Inhibition of amyloidosis using low-molecular-weight heparins. Mol Med 2001;7:517-22.
3. Jonas S, Sugimori M, Llinás R. Is low molecular weight heparin a neuroprotectant? Ann N Y Acad Sci 1997;825: 389-93.
4. Ma Q, Dudas B, Hejna M, Cornelli. U. Lee JM, Lorens S, et al. The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3. Thromb Res 2002; 105:447-53.
5. Zhang ZG, Zhang QZ, Cheng YN, Ji SL, Du GH. Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/reperfusion injury in rats. Pharmacol Res 2007;56:350-5.
6. Duarte AI., Santos MS, Oliveira CR, Rego AC. Insulin neuroprotection against oxidative stress in cortical neurons-involvement of uric acid and glutathione antioxidant defenses. Free Radic Biol Med 2005;39:876-89.
7. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
8. Cavaliere F, D'Ambrosi N, Sancesario G, Bernardi G, Volonté C. Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem Int 2001;38:199-207.
9. Wolozin B, Iwasaki K, Vito P, Ganjei JK, Lacanà E, Sunderland T, et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 1996;274:1710-3.
10. 2+, indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
11. Sur P, Sribnick EA, Wingrave JM, Nowak MW, Ray SK, Banik NL. Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res 2003;971:178-88.
12. Bleich S, Romer K, Wiltfang J, Kornhuber J. Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry 2003;18 (Suppl 1):S33-40.
13. Conn PJ. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann N Y Acad Sci 2003;1003:12-21.
14. Spillson AB, kussell JW. Metabotropic glutamate receptor regulation of neuronal cell death. Exp Neurol 2003;184 Suppl 1:S97-105.
15. Mori H, Mishina M. Roles of diverse glutamate receptors in brain functions elucidated by subunit-specific and region-specific gene targeting. Life Sci 2003;74:329-36.
16. Huettner JE. Kainate receptors and synaptic transmission. Prog Neurobiol 2003;70:387-407.
17. 2+ influx elicited by glutamate: role in neuronal death. Mol Pharmacol 1989;36:106-12.
18. Naarala JT, Loikkanen JJ, Ruotsalainen MH, Savolainen KM. Lead amplifies glutamate-induced oxidative stress. Free Radic Biol Med 1995;19:689-93.
19. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15: 961-73.
20. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987;7:369-79.
21. Koh JY, Yang LL, Cotman CW. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990;533:315-20.
22. Smith T, Groom A, Zhu B, Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000;6:62-6.
23. Turski L, Bressler K, Rettig KJ, Löschmann PA, Wachtel H. Protection of substantia nigra form MPP+ neurotoxicity by N-methyl-D-aspartate antagonists. Nature 1991;349:414-8.
24. Matsuzaki H, Tamatani M, Mitsuda N, Namikawa K, Kiyama H, Miyake S, et al. Activation of Akt kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitric oxide in primary hippocampal neurons. J Neurochem 1999;73:2037-46.
25. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990;13:171-82.
26. Kristián T, Siesjö BK. Calcium-related damage in ischemia. Life Sci 1996:59:357-67.
27. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci 2001;69:369-81.
28. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-2.
29. Ghosh TK, Eis PS, Mullaney JM, Ebert CL, Gill DL. Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J Biol Chem 1988;263:11075-9.
30. 2+ release from rat liver microsomes. FEBS Lett 1988;228:57-9.
31. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993;361:315-25.
32. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J 1995;9:219-28.
33. Pasquet JM, Dachary-Prigent J, Nurden AT. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 1996;239:647-54.
34. Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997;20:245-67.
35. Staunton MJ, Gaffney EF. Apoptosis: basic concepts and potential significance in human cancer. Arch Pathol Lab Med 1998;122:310-9.
36. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
37. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998;82:1111-29.
38. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996;74:86-107.
39. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
40. Huang Q, Singh B, Sharawy M. Immunohistochemical analysis of Bcl-2 and Bax oncoproteins in rabbit craniomandibular joint. Arch Oral Biol 2004;49:143-8.
41. Eves EM, Xiong W, Bellacosa A, Kennedy SG, Tsichlis PN, Rosner MR, et al. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol 1998;18:2143-52.
42. Zhong LT, Kane DJ, Bredesen DE. Bcl-2 blocks glutamate toxicity in neural cell lines. Brain Res Mol Brain Res 1993;19:353-5.
43. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-6.
44. Yang JN, Liu CX, Xu H, Pan QC. Caspases promoted DADAG-induced apoptosis in human leukemia HL-60 cells. Acta Pharmacol Sin 2002;23:461-6.
45. Daniel PT. Dissecting the pathways to death. Leukemia 2000;14:2035-44.
46. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosts. Science 1997;275:1132-6.
47. Chen J, Nagayama T, Jin K, Stetler RA, Zhu RI, Graham SH, et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998;18: 4914-28.
48. Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, et al. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol Lett 2003;139:125-33.
49. Hills FA, Abrahams VM, González-Timón B, Francis J, Cloke B, Hinkson L, et al. Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 2006;12:237-43.
50. Deepa PR, Varalakshmi P. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology 2006;217:176-83.